eli lilly zepbound tirzepatide Lilly's in shortage months after approval Trial shows Lilly's Zepbound helps

Changes in Body Weight at Week 68 in Study 6 in East-Asian Patients (WEGOVY 1.7 mg) LSMean = least squares mean

Also, in combination with other medicinal products for the treatment of Type 2 diabetes." Limitations of Use Has not been studied in patients with a history of pancreatitis

10.1016/s0896-6273(04)00048-0 Summary Keywords tirzepatide, diabetes mellitus, spatial learning and memory, A, synaptic plasticity, inflammation, insulin Citation Guo X, Lei M, Zhao J, Wu M, Ren Z, Yang X, Ouyang C, Liu X, Liu C and Chen Q (2023) Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats

Li R, Yang W